Takeda Pharmaceutical

(OTC) TKPHF

Current Price$32.26

Market Cap$51.64B

Since IPO (2003)-6%

5 Year+18%

1 Year+30%

1 Month-5%

Takeda Pharmaceutical Financials at a Glance

Market Cap

$51.64B

Revenue (TTM)

$4.51T

Net Income (TTM)

$191.70B

EPS (TTM)

$0.81

P/E Ratio

39.61

Dividend

$1.30

Beta (Volatility)

0.07 (Low)

Dividend

$1.30

Beta (Volatility)

0.07 (Low)

Price

$32.26

Volume

230

Open

$32.26

Price

$32.26

Volume

230

Open

$32.26

Previous Close

$32.26

Daily Range

$32.26 - $32.26

52-Week Range

$26.30 - $39.20

Dividend

$1.30

Beta (Volatility)

0.07 (Low)

Price

$32.26

Volume

230

Open

$32.26

Previous Close

$32.26

Daily Range

$32.26 - $32.26

52-Week Range

$26.30 - $39.20

TKPHF News

Why Is Everybody Talking About Novavax Stock?

Taylor CarmichaelDec 30, 2020

Why ImmunoGen Inc. is Soaring Higher Today

Todd CampbellMar 23, 2015

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Takeda Pharmaceutical

Industry

Pharmaceuticals

Sector

Health Care

Employees

47,455

CEO

Christophe Weber, PhD

Website

www.takeda.com

Headquarters

Tokyo, 103-8668, JP

TKPHF Financials

Key Financial Metrics (TTM)

Gross Margin

59%

Operating Margin

11%

Net Income Margin

Return on Equity

Return on Capital

Return on Assets

Earnings Yield

2.52%

Dividend Yield

3.99%

Payout Ratio

1.63%

Stock Overview

Market Cap

$51.64B

Shares Outstanding

1.58B

Volume

230

Avg. Volume

32.66K

Financials (TTM)

Gross Profit

$2.32T

Operating Income

$543.85B

EBITDA

$1.27T

Operating Cash Flow

$944.62B

Capital Expenditure

$177.11B

Free Cash Flow

$767.51B

Cash & ST Invst.

$598.80B

Total Debt

$4.91T

Takeda Pharmaceutical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$1.10T

+4.6%

Gross Profit

$537.36B

-20.0%

Gross Margin

48.79%

N/A

Market Cap

$51.64B

N/A

Market Cap/Employee

$1.05M

N/A

Employees

49,281

N/A

Net Income

$24.47B

+76.3%

EBITDA

$211.88B

+188.9%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$4.31T

-5.0%

Accounts Receivable

$881.86B

+21.6%

Inventory

$1.41T

+15.4%

Long Term Debt

$4.40T

+10.9%

Short Term Debt

$515.38B

-6.1%

Return on Assets

1.24%

N/A

Return on Invested Capital

3.65%

N/A

Free Cash Flow

$6.03B

-104.7%

Operating Cash Flow

$40.62B

-81.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

WUXAYWuXi AppTec Co., Ltd.

WUXAYWuXi AppTec Co., Ltd.$15.99-4.33%

HOCPFHOYA Corporation

HOCPFHOYA Corporation$176.17+3.22%

LZAGYLonza Group AG

LZAGYLonza Group AG$59.77+0.68%

WUXIFWuXi AppTec Co., Ltd.

WUXIFWuXi AppTec Co., Ltd.$13.88+0.00%

HLNCFHaleon plc

HLNCFHaleon plc$4.54+2.02%

IPSEYIpsen S.A.

IPSEYIpsen S.A.$48.76-0.20%

SDZNYSandoz Group AG

SDZNYSandoz Group AG$83.23-0.01%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.20-0.06%

TET1 Energy Inc.

TET1 Energy Inc.$7.00+0.23%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$74.32-0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.54+0.01%

ONDSOndas

ONDSOndas$9.70-0.09%

FFord Motor Company

FFord Motor Company$13.03-0.03%

RIGTransocean

RIGTransocean$7.58+0.08%

Questions About TKPHF

What is the current price of Takeda Pharmaceutical?

Takeda Pharmaceutical is trading at $32.26 per share.

What is the 52-week range for Takeda Pharmaceutical?

Over the past 52 weeks, Takeda Pharmaceutical has traded between $26.30 and $39.20.

How much debt does Takeda Pharmaceutical have?

As of the most recent reporting period, Takeda Pharmaceutical reported total debt of $30.69B.

How much cash does Takeda Pharmaceutical have on hand?

Takeda Pharmaceutical reported $3.74B in cash and cash equivalents in its most recent financial results.

What is Takeda Pharmaceutical’s dividend yield?

Takeda Pharmaceutical currently has a dividend yield of 3.99%.

Takeda Pharmaceutical

Takeda Pharmaceutical Financials at a Glance

TKPHF News

Why Is Everybody Talking About Novavax Stock?

Why ImmunoGen Inc. is Soaring Higher Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Takeda Pharmaceutical

TKPHF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Takeda Pharmaceutical Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TKPHF

What is the current price of Takeda Pharmaceutical?

What is the 52-week range for Takeda Pharmaceutical?

How much debt does Takeda Pharmaceutical have?

How much cash does Takeda Pharmaceutical have on hand?

What is Takeda Pharmaceutical’s dividend yield?

Premium Investing Services